Early complications of prenatal invasive diagnostics: Perspective analysis

Acta Biomedica de l'Ateneo Parmense

Volumn 75, Issue SUPPL. 1, 2004, Pages 23-26

  Cavallotti, Davide ^a   Casilla, Giovanna ^a   Piantelli, Giovanni ^a   Verrotti, Carla ^a   Fieni, Stefania ^a   Gramellini, Dandolo ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Amniocentesis; Chorionic villus sampling; Fetal loss rate

Indexed keywords

ADULT; AMNIOCENTESIS; CHORION VILLUS SAMPLING; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; EARLY DIAGNOSIS; FEMALE; FETUS; FETUS WASTAGE; FEVER; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MUSCLE SPASM; PELVIS PAIN SYNDROME; POSTOPERATIVE PERIOD; PRENATAL DIAGNOSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; UTERUS MYOMA; VAGINA BLEEDING;

ABORTION, SPONTANEOUS; ADULT; AMNIOCENTESIS; CHORIONIC VILLI SAMPLING; FEMALE; FETAL DISEASES; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES;

EID: 4043101838     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (12)

1. Hogge WA, Schonberg SA, Golbus MS. Chorionic villus sampling experience of the first 1000 cases. Am J Obstet Gynecol 1986; 154: 1246-52.
2. Elias S, Simpson JL, Shulman LP, et al. Transabdominal chorionic vilus sampling for first trimester prenatal diagnosis. Am J Obstet Gynecol 1989; 160: 87.
3. Department of Obstetrics and Gynaecology Tietung Hospital of Anshan Iron and Steel Company: Fetal sex Prediction by chromatin of chorionic villi cells during early pregnancy. Chin Med J 1975; 1: 117-26.
4. Tabor A. Genetic amniocentesis-indication and risks. Dan Med Bull 1988; 35 (6): 520-37.
5. Tharmaratnam S, Sadek S, Steele EK, Harper MA, Nevin NC, Dornan JC. Transplacental early amniocentesis and pregnancy outcome. Royal Maternity Hospital, Belfast 1998; 105: 228-30.
6. Sundberg K, Bang, Smidt-Jensen S, et al. Randomised study of risk of fetal loss related to early amniocentesis versus chorionic villus sampling. Department of Clinical genetic, Copenhagen, Denmark. Lancet 1997; 350: 1253-4.
7. Vergani P, Locatelli A, et al. Risk factors for pulmonary Hypoplasia in second-trimester premature rupture of membranes. Am J Obstet Gynecol 1994; 170: 1359-64.
8. Saltvedt S, Almstrom H. Fetal loss rate after second trimester amniocentesis at different gestational age. Acta Obstet Gynecol Scand 1999; 78 (1): 10-4.
9. Williamson RA, Varner MW, Grant SS. Reduction in amniocentesis risks using a real time needle guide puncture. Obstet Gynecol 1985; 65: 751.
10. Papantoniou NE, Daskalakis GJ, et al. Risk factors predisposing to fetal loss following a second trimester amniocentesis. Br J Obstet Gynecol 2001; 108: 1053-6.
11. Antsaklis A, Papantoniou N, et al. Genetic amniocentesis in women 20-34 years old: associated risks. Prenat Diagn 2000; 20: 247-50.
12. Alfirevic Z, Sundberg K, Brigham S. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev 2003; 3.